Synthetic K receptor agonist for pain therapy – Novel class of k selective opioids for peripheral pain treatment

Natural and synthetic opioids are effective and widely

used drugs for the treatment of acute, post-operative or malignant pain. These drugs interact predominantly with μ-opioid receptors in the central nervous system. While being strong analgesics, these drugs also cause severe side effects due to their interaction with μ-opioid receptors in the brain. This limits the use of currently available opioids for palliative care. Not many drugs are available for the treatment of severe peripheral, chronic, neuropathic or non-malignant pain. However, k-opioid receptor agonists with high k receptor affinity and selectivity, which cannot pass the blood brain barrier, are suitable for this purpose. At the University of Münster, a new class of compounds with high k receptor affinity and selectivity as well as strong analgesic effects has been developed.

Further Information: PDF

PROvendis GmbH
Phone: +49 (0)208/94105 0

Contact
Dipl.-Ing. Alfred Schillert

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Superradiant atoms could push the boundaries of how precisely time can be measured

Superradiant atoms can help us measure time more precisely than ever. In a new study, researchers from the University of Copenhagen present a new method for measuring the time interval,…

Ion thermoelectric conversion devices for near room temperature

The electrode sheet of the thermoelectric device consists of ionic hydrogel, which is sandwiched between the electrodes to form, and the Prussian blue on the electrode undergoes a redox reaction…

Zap Energy achieves 37-million-degree temperatures in a compact device

New publication reports record electron temperatures for a small-scale, sheared-flow-stabilized Z-pinch fusion device. In the nine decades since humans first produced fusion reactions, only a few fusion technologies have demonstrated…

Partners & Sponsors